{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:24:19Z","timestamp":1770747859924,"version":"3.49.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":144,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>PsA and gout are two prevalent rheumatic diseases, that can be associated as part of a rheumatism known as \u2018Psout\u2019. Both conditions are associated with cardiovascular (CV) risk, thus their co-occurrence could have significant implications for the management of CV risks and patient care. This study aimed to determine the prevalence of gout within a PsA patient cohort and, consequently, to identify factors associated with this pathological association.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is an observational, descriptive, cross-sectional, single-center study, including patients diagnosed with PsA. Demographic, clinical, biological and imaging data were collected. We identified the proportion of patients simultaneously affected by PsA and gout and compared characteristics between those with and without gout.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The prevalence of gout among PSA patients was 9.8% (12\/122), with a prevalence of 23% for asymptomatic hyperuricemia and 7.4% presenting with specific US signs of gout. Significant associated factors in the univariate analysis included weight, hypertension, diabetes, certain medications (diuretics, aspirin, lipid-lowering agents), impaired renal function, elevated fasting blood glucose, lipid abnormalities and specific US signs of gout.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our study has described the existence of patients simultaneously affected by PsA and gout (\u2018Psout\u2019). Performing joint US along with uric acid level measurements in PsA patients can enable personalized therapeutic care.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rap\/rkae069","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T22:07:37Z","timestamp":1716588457000},"source":"Crossref","is-referenced-by-count":2,"title":["Interest in daily clinical practice of screening for gouty disease in patients with psoriatic arthritis"],"prefix":"10.1093","volume":"8","author":[{"given":"Vanessa","family":"Moukarzel","sequence":"first","affiliation":[{"name":"Department of Rheumatology, University Hospital of Amiens , Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5077-1370","authenticated-orcid":false,"given":"Marie","family":"Doussi\u00e8re","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital of Amiens , Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Barbier","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Centre Hospitalier de Corbie , Corbie, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimmy","family":"Menis","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital of Amiens , Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Le Monnier","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital of Amiens , Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Salomon-Go\u00ebb","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital of Amiens , Amiens, France"},{"name":"Department of Rheumatology, Clinique Victor Pauchet , Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxime","family":"Aboudiab","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital of Amiens , Amiens, France"},{"name":"Department of Rheumatology, Centre Hospitalier de Beauvais , Beauvais, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Go\u00ebb","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, University Hospital of Amiens , Amiens, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"2024060715064966800_rkae069-B1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/rheumatology\/keaa448","article-title":"Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance database","volume":"60","author":"Pina Vegas","year":"2021","journal-title":"Rheumatology"},{"key":"2024060715064966800_rkae069-B2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3899\/jrheum.160180","article-title":"Mapping the effect of psoriatic arthritis using the international classification of functioning, disability and health","volume":"44","author":"Gudu","year":"2017","journal-title":"J Rheumatol"},{"key":"2024060715064966800_rkae069-B3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/acr.22660","article-title":"Prevalence of gout in the adult population of France","volume":"68","author":"Bardin","year":"2016","journal-title":"Arthritis Care Res"},{"key":"2024060715064966800_rkae069-B4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/annrheumdis-2013-204463","article-title":"Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study","volume":"74","author":"Kuo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2024060715064966800_rkae069-B5","doi-asserted-by":"crossref","first-page":"105335","DOI":"10.1016\/j.jbspin.2021.105335","article-title":"Update of the current role of ultrasound in asymptomatic hyperuricemia. A systematic literature review","volume":"89","author":"Gutierrez","year":"2022","journal-title":"Joint Bone Spine"},{"key":"2024060715064966800_rkae069-B6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/ard.2006.055251","article-title":"EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2024060715064966800_rkae069-B7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2019-215315","article-title":"2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout","volume":"79","author":"Richette","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2024060715064966800_rkae069-B8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/ard.2011.154997","article-title":"Diagnosis of gout in patients with asymptomatic hyperuricaemia: a pilot ultrasound study","volume":"71","author":"De Miguel","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"2024060715064966800_rkae069-B9","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/rheumatology\/kev112","article-title":"International Consensus for ultrasound lesions in gout: results of Delphi process and web-reliability exercise","volume":"54","author":"Gutierrez","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"2024060715064966800_rkae069-B10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/art.39959","article-title":"Performance of ultrasound in the diagnosis of gout in a multicenter study: comparison with monosodium urate monohydrate crystal analysis as the gold standard","volume":"69","author":"Ogdie","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2024060715064966800_rkae069-B11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1590\/abd1806-4841.20174895","article-title":"Chronic tophaceous gout in patients with psoriasis","volume":"92","author":"Lobato","year":"2017","journal-title":"An Bras Dermatol"},{"key":"2024060715064966800_rkae069-B12","first-page":"213","article-title":"Psoriatic arthropathy and crystal-induced synovitis","volume":"7","author":"Venkatasubramaniam","year":"1980","journal-title":"J Rheumatol"},{"key":"2024060715064966800_rkae069-B13","first-page":"220","article-title":"Gout mimicking psoriatic arthritis flare","volume":"18","author":"L\u00f3pez-Reyes","year":"2012","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"2024060715064966800_rkae069-B14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF02041566","article-title":"Psoriasis and gout: report of 4 cases","volume":"2","author":"Bosmansky","year":"1983","journal-title":"Clin Rheumatol"},{"key":"2024060715064966800_rkae069-B15","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/annrheumdis-2014-205212","article-title":"Psoriasis, psoriatic arthritis and risk of gout in US men and women","volume":"74","author":"Merola","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2024060715064966800_rkae069-B16","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s10067-020-04981-0","article-title":"At the crossroads of gout and psoriatic arthritis: \u201cpsout\u201d","volume":"39","author":"Felten","year":"2020","journal-title":"Clin Rheumatol"},{"key":"2024060715064966800_rkae069-B17","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/1346-8138.12961","article-title":"Psoriatic T cells reduce epidermal turnover time and affect cell proliferation contributed from differential gene expression","volume":"42","author":"Li","year":"2015","journal-title":"J Dermatol"},{"key":"2024060715064966800_rkae069-B18","doi-asserted-by":"crossref","first-page":"104351","DOI":"10.1016\/j.phrs.2019.104351","article-title":"IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation","volume":"147","author":"Raucci","year":"2019","journal-title":"Pharmacol Res"},{"key":"2024060715064966800_rkae069-B19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00296-020-04775-2","article-title":"Comorbidities in psoriatic arthritis: a systematic review and meta-analysis","volume":"41","author":"Gupta","year":"2021","journal-title":"Rheumatol Int"},{"key":"2024060715064966800_rkae069-B20","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/S0140-6736(18)31366-7","article-title":"Gout","volume":"391","author":"Barnett","year":"2018","journal-title":"Lancet Lond Engl"},{"key":"2024060715064966800_rkae069-B21","first-page":"67"},{"key":"2024060715064966800_rkae069-B22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","article-title":"Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study","volume":"74","author":"Ogdie","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2024060715064966800_rkae069-B23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40292-014-0046-3","article-title":"Hyperuricemia and cardiovascular risk","volume":"21","author":"Grassi","year":"2014","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"2024060715064966800_rkae069-B24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12872-019-1215-z","article-title":"Serum uric acid and risk of cardiovascular mortality: a systematic review and dose-response meta-analysis of cohort studies of over a million participants","volume":"19","author":"Rahimi-Sakak","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"2024060715064966800_rkae069-B25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2016.10.009","article-title":"Management of psoriatic arthritis: early diagnosis, monitoring of disease severity and cutting edge therapies","volume":"76","author":"Raychaudhuri","year":"2017","journal-title":"J Autoimmun"},{"key":"2024060715064966800_rkae069-B26","first-page":"84","article-title":"Current characteristics of a population of psoriatic arthritis and gender disparities","volume":"9","author":"Menis","year":"2023","journal-title":"J Clin Transl Res"},{"key":"2024060715064966800_rkae069-B27"},{"key":"2024060715064966800_rkae069-B28","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/art.39254","article-title":"Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative: ACR\/EULAR classification criteria for gout","volume":"67","author":"Neogi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2024060715064966800_rkae069-B29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jbspin.2015.01.002","article-title":"Hyperuricemia starts at 360 micromoles (6 mg\/dL)","volume":"82","author":"Bardin","year":"2015","journal-title":"Joint Bone Spine"},{"key":"2024060715064966800_rkae069-B30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2024060715064966800_rkae069-B31","first-page":"122","article-title":"Higher incidence rates of comorbidities in patients with psoriatic arthritis compared with the general population using U.S. administrative claims data","volume":"25","author":"Kaine","year":"2019","journal-title":"J Manag Care Spec Pharm"},{"key":"2024060715064966800_rkae069-B32","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10067-022-06061-x","article-title":"Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat","volume":"41","author":"Widawski","year":"2022","journal-title":"Clin Rheumatol"},{"key":"2024060715064966800_rkae069-B33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/1756-185X.13265","article-title":"Hyperuricemia in Asian psoriatic arthritis patients","volume":"21","author":"Lai","year":"2018","journal-title":"Int J Rheum Dis"},{"key":"2024060715064966800_rkae069-B34","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3899\/jrheum.170384","article-title":"Characteristic and outcome of psoriatic arthritis patients with hyperuricemia","volume":"45","author":"AlJohani","year":"2018","journal-title":"J Rheumatol"},{"key":"2024060715064966800_rkae069-B35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00124743-200002000-00001","article-title":"Hyperuricemia in psoriatic arthritis prevalence and associated features","volume":"6","author":"Bruce","year":"2000","journal-title":"JCR J Clin Rheumatol"},{"key":"2024060715064966800_rkae069-B36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/art.1780150209","article-title":"The influence of temperature on the solubility of monosodium urate","volume":"15","author":"Loeb","year":"1972","journal-title":"Arthritis Rheum"},{"key":"2024060715064966800_rkae069-B37","first-page":"245","article-title":"\u00c9pid\u00e9miologie du rhumatisme psoriasique","volume":"87","author":"Lukas","year":"2020","journal-title":"Rev Rhum Monogr"},{"key":"2024060715064966800_rkae069-B38","first-page":"120","article-title":"Clinical specialty setting as determinant of management of psoriatic arthritis: a cross-sectional Brazilian study","volume":"28","author":"da Silva Souza","year":"2022","journal-title":"J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"key":"2024060715064966800_rkae069-B39","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1136\/annrheumdis-2016-210963","article-title":"Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study","volume":"76","author":"Egeberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2024060715064966800_rkae069-B40","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1002\/art.41741","article-title":"The epidemiology of psoriatic arthritis over five decades: a population-based study","volume":"73","author":"Karmacharya","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2024060715064966800_rkae069-B41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/annrheumdis-2012-202589","article-title":"Low-dose aspirin use and recurrent gout attacks","volume":"73","author":"Zhang","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2024060715064966800_rkae069-B42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/RHU.0000000000000898","article-title":"Ultrasonographic features of lower-limb joints in gout: which joints and clinical characteristics would provide more information for diagnosis?","volume":"26","author":"Zhang","year":"2020","journal-title":"JCR J Clin Rheumatol"},{"key":"2024060715064966800_rkae069-B43","first-page":"264","article-title":"Articular cartilage of knee and first MTP joint are the preferred sites to find double contour sign as an evidence of urate crystal deposition in asymptomatic hyperuricemic individuals","volume":"43","author":"Bhadu","year":"2018","journal-title":"Acta Reumatol Port"},{"key":"2024060715064966800_rkae069-B44","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jbspin.2013.10.008","article-title":"The hypouricemiant effect of leflunomide","volume":"81","author":"Arida","year":"2014","journal-title":"Joint Bone Spine"},{"key":"2024060715064966800_rkae069-B45","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1038\/s41598-022-07695-2","article-title":"Lumbar zygapophyseal joints injections under ultrasound guidance an alternative to fluoroscopy guidance in the management of low back pain","volume":"12","author":"Touboul","year":"2022","journal-title":"Sci Rep"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkae069\/57890187\/rkae069.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/8\/3\/rkae069\/58165129\/rkae069.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/8\/3\/rkae069\/58165129\/rkae069.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T16:20:32Z","timestamp":1717777232000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkae069\/7681897"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6,7]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkae069","relation":{},"ISSN":["2514-1775"],"issn-type":[{"value":"2514-1775","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024]]},"published":{"date-parts":[[2024]]},"article-number":"rkae069"}}